Par Pharm
Article Abstract:
The shares of Par Pharmaceutical Companies Inc. have a modest price appreciation potential over the 2010-2012 timeframe. The Spring Valley, New York-based company's principal subsidiary, Pharm. Resources, manufactures and distributes generic drugs in the United States.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Par Pharmaceutical Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
PDL BioPharma
Article Abstract:
The shares of PDL BioPharma Inc. have an above average price appreciation potential over the 2010-2012 timeframe. The Redwood City, California-based company develops humanized antibodies and other proteins for the prevention or treatment of various diseases.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
United States
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Pharmaceutical industry, Stocks, Securities, Stock prices, Company securities, Analyst report
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.